Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4/A Grant or award Director acquired 75,000 shares (grant or award)
  3. 4/A Grant or award Director acquired 300,000 shares (grant or award)
  4. 4/A Grant or award Cheif Operating Officer acquired 300,000 shares (grant or award)
  5. 4/A Grant or award Executive Chairman acquired 375,000 shares (grant or award)
  6. 4 Grant or award Director acquired 75,000 shares (grant or award)
  7. 4 Grant or award Director acquired 300,000 shares (grant or award)
  8. 4 Grant or award Vice President Finance acquired 75,000 shares (grant or award)
  9. 4 Grant or award Chief Operating Officer acquired 300,000 shares (grant or award)
  10. 4 Grant or award Executive Chairman acquired 375,000 shares (grant or award)
  11. 4 Open-market buy Director bought 25,000 shares at $4.00 ($100,000)
  12. 4/A Open-market buy Director bought 250,000 shares at $4.00 ($1,000,000)
  13. 4 Open-market buy Director bought 62,500 shares at $4.00 ($250,000)
  14. 4 Open-market buy Director bought 250,000 shares at $4.00 ($1,000,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale 10% owner sold 204,157 shares at an average $0.57 ($115,949)

Page 17 of 20 · 394 filings